About the Product

Description


Mirtafoam 45 Tablet containing Mirtazapine is used for the management of depression and mood-related disorders. It helps improve emotional balance, sleep quality, and overall mental well-being under medical supervision.

Mirtazapine works as an antidepressant by modulating neurotransmitters such as serotonin and norepinephrine, helping restore chemical balance in the brain and improve mood stability.

The tablet is widely prescribed in psychiatric practice for depression, anxiety-related conditions, and sleep disturbances associated with mood disorders, leading to consistent prescription demand.

With increasing awareness of mental health care and growing demand for effective antidepressant therapies, this product offers strong business potential for retailers and distributors. Its established therapeutic profile, dual-action mood and sleep benefits, and steady market demand make it a reliable product for growth in the neuropsychiatric segment.

Some patients may experience drowsiness, increased appetite, weight gain, dry mouth, dizziness, constipation, or fatigue. Rarely, low white blood cell count, severe mood changes, or allergic reactions may occur and require immediate medical attention.

Mirtafoam 45 Tablet is indicated for major depressive disorder, depression associated with anxiety, sleep disturbances linked with depression, and other mood disorders as prescribed by a healthcare professional. It helps improve mood stability, emotional balance, and sleep quality.

This medicine should be used strictly under medical supervision. It may cause sedation, so caution is advised while driving or operating machinery. Do not stop the medication abruptly without medical advice. Patients should be monitored for mood changes, especially at the beginning of therapy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Mirtazapine 45mg Tablet in the PCD pharma franchise market?

Mirtazapine 45mg Tablet has strong demand in the psychiatry, neurology, and mental health segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on antidepressant and CNS therapy portfolios.

Why should medical distributors include Mirtazapine 45mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for depression and anxiety-related disorders under medical supervision. Mirtazapine 45mg is an antidepressant that helps balance neurotransmitters like serotonin and norepinephrine Commonly prescribed for major depressive disorder, anxiety disorders, sleep disturbances associated with depression, and mood disorders Also helps improve appetite and sleep quality in selected patients Widely used by psychiatrists and general physicians for long-term mental health management This strengthens a comprehensive neuro-psychiatry and CNS care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Mirtazapine 45mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady psychiatric prescriptions, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the CNS segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.